This indicated that the expression of TMEM54 and PLCG2 was related to PCOS and that combination of these two genes could be used as a biomarker for distinguishing PCOS from healthy women of reproductive age and for evaluating the efficacy of PCOS treatment (Fig. 8). Here, TMEM54 is linked to polycystic ovary syndrome.